Patents and Public Health
State Responsibility to Opt for a Balanced Approach
Bibliographic Data
| ID | 13024898 |
|---|---|
| Authors | Saima Akram Butt (0000-0002-7438-6917, International Islamic University, Islamabad), Kamran Shaukat (0000-0003-2174-3383, University of the Punjab, corresponding author), Talha Mahboob Alam (0000-0001-7228-0046, Norwegian University of Science and Technology, corresponding author), Tony Jan (0000-0002-3114-8978, Torrens University Australia) |
| Year | 2024 |
| Volume | 14 |
| Issue | 8 |
| Pages | 152-152 |
| Publication date | 2024-08-13 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Societies (JOURNAL) |
| Journal identifiers | ISSN: 2075-4698 • E-ISSN: 2075-4698 |
| Publisher | MDPI AG (PUBLISHER • IT) |
| DOI | 10.3390/soc14080152 |
| OpenAlex | W4401546893 |
| Language | EN |
| Citations received | 1 |
| References cited | 16 |
The topic of public health is indispensable to talk about. It is essential to discuss new inventions, new and improved treatments, and their efficiencies with different combinations, but one thing that is important to remember is whether these inventions are available for those in need. Availability concerns are linked with affordability, as the affordability of a drug determines its consumption; furthermore, affordability can lead to overconsumption. The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement provides flexibility to control the misuse of patent monopolies. The object of this research is twofold: one is to investigate whether and how Pakistan incorporates TRIPS flexibilities in its national patent legislation, and the second is to find out the reason for unaffordable cancer treatment in Pakistan. This research highlights that the use of TRIPS flexibilities in Pakistan will help the state authorities to provide better health facilities to the public generally as well as particularly in cancer cases, as cancer treatment in Pakistan is unaffordable. The methodology applied for this research is primarily comparative and bears the qualitative aspect of the issue. This research concludes that Pakistan’s legal system fails to incorporate effective legal provisions related to TRIPS flexibilities, and it also highlights that the ever-greening of patents results in the high prices of cancer medicines in Pakistan. This research further recommended that there is a dire need to incorporate and use TRIPS flexibilities in the country to control the high prices of cancer treatment and cancer mortality rate in the country
Business · Economic growth · Economics · Flexibility (engineering · Intellectual property · Legislation · Overconsumption · Political science · Public economics · TRIPS Agreement · TRIPS architecture · Engineering · Health Systems, Economic Evaluations, Quality of Life · Intellectual Property and Patents · Law · Pharmaceutical Economics and Policy
“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”
Universal access to essential medicines as part of the right to health
Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan
The financial burden of cancer
The role of intellectual property rights on access to medicines in the WHO African region
The Right to Health Care and The State
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |